Evolent HealthEVH +3.08%60 FCF Yield % is 0.24 as of Jun. 26, 2026. GuruFocus rates EVH with a GF Score™ of 60/100 and a GF Value™ of $11.07 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 687 Healthcare Providers & Services companies, Evolent Health ranks worse than 56.48% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Evolent Health FCF Yield % Related Terms
Evolent Health FCF Yield % Historical Data
* Premium members only.
The historical data trend for Evolent Health's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Evolent Health's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Evolent Health FCF Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Evolent Health's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Evolent Health's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Evolent Health (EVH) has a FCF Yield % of 0.24 as of Jun. 26, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Evolent Health and its competitors. According to the industry distribution chart, Evolent Health ranks #388 out of 687 companies in the Healthcare Providers & Services industry, placing it in the top 56.5%.
Is Evolent Health's FCF Yield % too high?
Evolent Health's current FCF Yield % is 0.24. The Healthcare Providers & Services industry median FCF Yield % is 1.91. Evolent Health's value of 0.24 is 87.4% below this industry median. Based on the distribution chart, Evolent Health ranks #388 out of 687 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Evolent Health has a GF Score™ of 60/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Evolent Health's FCF Yield % compare to NRC and CTEV?
According to the Healthcare Providers & Services industry distribution chart, Evolent Health ranks #388 out of 687 companies for FCF Yield %. This places Evolent Health in the lower half of its industry. The industry median FCF Yield % is 1.91. Evolent Health's value of 0.24 is 87.4% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Healthcare Providers & Services company?
The median FCF Yield % among Healthcare Providers & Services companies is 1.91, based on 687 companies in the industry. Companies in the top quartile (top 25%) have a FCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Evolent Health's current FCF Yield % of 0.24 is 87.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Evolent Health and its competitors. For the Healthcare Providers & Services industry, the median FCF Yield % is 1.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Evolent Health's current FCF Yield % is 0.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Evolent Health stock overvalued right now?
Based on GuruFocus' analysis, Evolent Health (EVH) is currently considered Possible Value Trap. The stock's GF Value™ is $11.07, compared to a current price of $5.19 — trading 53.2% below its estimated fair value. The current FCF Yield % is 0.24 and 87.4% below the Healthcare Providers & Services industry median of 1.91. Evolent Health's overall GF Score™ is 60/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Evolent Health (EVH), the current FCF Yield % is 0.24 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Evolent Health (EVH) Overvalued in 2026?
Based on GuruFocus' analysis, Evolent Health stock appears to be undervalued.
The current stock price of $5.19 is trading 53.2% below its estimated GF Value™ of $11.07.
GuruFocus considers Evolent Health to be Possible Value Trap.
Key valuation signals for EVH:
FCF Yield %: 0.24
GF Value™: $11.07 vs. price of $5.19 (53.2% below fair value)
Industry Position: 87.4% below the Healthcare Providers & Services median (#388 of 687)
No single metric tells the full story. See the EVH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The solutions provided by the company includes: Oncology, Cardiology, Musculoskeletal, Administrative Services, Advanced Illness, Genetic Testing, Physical Medicine, Radiology, and Surgical Management.
60GF Score
Get the complete analysis for EVH
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
EVH has been successfully added to your 
